Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Khoury, H; Adkins, D; Brown, R; Pence, H; Vij, R; Goodnough, LT; Westervelt, P; Trinkaus, K; Lin, HS; DiPersio, J
   Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen
   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
   
   H. Khoury et al., "Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen", BIOL BLOOD, 7(6), 2001, pp. 352-358
2. Vij, R; DiPersio, J; Brown, R; Trinkaus, K; Abboud, C; Meehan, KR; Frenette, G; Freytes, C; Goodnough, LT; Khoury, H; Ponnuri, J; Adkins, D
   Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation
   BONE MARROW TRANSPLANTATION
   
   R. Vij et al., "Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation", BONE MAR TR, 26(9), 2000, pp. 947-953
3. Khoury, H; Adkins, D; Brown, R; Trinkaus, K; Vij, R; Miller, G; Goodnough, LT; DiPersio, J
   Does early treatment with high-dose methylprednisolone alter the course ofhepatic regimen-related toxicity?
   BONE MARROW TRANSPLANTATION
   
   H. Khoury et al., "Does early treatment with high-dose methylprednisolone alter the course ofhepatic regimen-related toxicity?", BONE MAR TR, 25(7), 2000, pp. 737-743
4. Vij, R; Brown, R; Shenoy, S; Haug, JS; Kaesberg, D; Adkins, D; Goodnough, LT; Khoury, H; DiPersio, J
   Allogeneic peripheral blood stem cell transplantation following CD34(+) enrichment by density gradient separation
   BONE MARROW TRANSPLANTATION
   
   R. Vij et al., "Allogeneic peripheral blood stem cell transplantation following CD34(+) enrichment by density gradient separation", BONE MAR TR, 25(12), 2000, pp. 1223-1228
5. Khoury, H; Adkins, D; Brown, R; Vij, R; Westervelt, P; Trinkaus, K; Goodnough, LT; DiPersio, JF
   Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation
   BONE MARROW TRANSPLANTATION
   
   H. Khoury et al., "Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation", BONE MAR TR, 25(11), 2000, pp. 1197-1201
6. Adkins, D
   Granulocyte transfusions
   VOX SANGUINIS
   
   D. Adkins, "Granulocyte transfusions", VOX SANGUIN, 79(1), 2000, pp. 63-63
7. Spitzer, G; Meehan, K; Adkins, D
   High-dose therapy for primary and metastatic breast cancer
   HEMATOPOIETIC STEM CELL TRANSPLANTION
   
   G. Spitzer et al., "High-dose therapy for primary and metastatic breast cancer", HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 517-536
8. Thornton, AC; Adkins, D; Arno, J
   Sexually transmitted diseases
   MANAGEMENT OF ANTIMICROBIALS IN INFECTIOUS DISEASES
   
   A.C. Thornton et al., "Sexually transmitted diseases", INFEC DIS S, 2000, pp. 185-215
9. Adkins, D; Brown, R; Trinkaus, K; Maziarz, R; Luedke, S; Freytes, C; Needles, B; Wienski, D; Fracasso, P; Pluard, T; Moriconi, W; Ryan, T; Hoelzer, K; Safdar, S; Rearden, T; Rodriguez, G; Khoury, H; Vij, R; DiPersio, J
   Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   D. Adkins et al., "Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer", J CL ONCOL, 17(7), 1999, pp. 2006-2014
10. Adkins, D; Brown, R; Goodnough, L; Khoury, H; DiPersio, J
    Purine analog regimens for allogeneic transplant?
    JOURNAL OF CLINICAL ONCOLOGY
    
    D. Adkins et al., "Purine analog regimens for allogeneic transplant?", J CL ONCOL, 17(6), 1999, pp. 1958-1959
11. Brown, RA; Adkins, D; Khoury, H; Vij, R; Goodnough, LT; Shenoy, S; DiPersio, JF
    Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: Graft-versus-host disease and transplant-related mortality
    JOURNAL OF CLINICAL ONCOLOGY
    
    R.A. Brown et al., "Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: Graft-versus-host disease and transplant-related mortality", J CL ONCOL, 17(3), 1999, pp. 806-812
12. Naughton, M; Brown, R; Adkins, D; DiPersio, J
    Tularemia - an unusual cause of a solitary pulmonary nodule in the post-transplant setting
    BONE MARROW TRANSPLANTATION
    
    M. Naughton et al., "Tularemia - an unusual cause of a solitary pulmonary nodule in the post-transplant setting", BONE MAR TR, 24(2), 1999, pp. 197-199
13. Khoury, H; Adkins, D; Brown, R; Goodnough, L; Gokden, M; Roberts, T; Storch, G; DiPersio, J
    Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection
    BONE MARROW TRANSPLANTATION
    
    H. Khoury et al., "Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection", BONE MAR TR, 23(4), 1999, pp. 409-411
14. Bodo, I; Peters, M; Radich, JP; Hess, J; Blinder, M; Watson, MS; Van Rheeden, R; Natarajan, S; Lowell, JA; Brown, R; DiPersio, J; Adkins, D
    Donor-derived acute promyelocytic leukemia in a liver-transplant recipient
    NEW ENGLAND JOURNAL OF MEDICINE
    
    I. Bodo et al., "Donor-derived acute promyelocytic leukemia in a liver-transplant recipient", N ENG J MED, 341(11), 1999, pp. 807-813
15. ADKINS D; JOHNSTON M; WALSH J; SPITZER G; GOODNOUGH T
    HYDROXYETHYLSTARCH SEDIMENTATION BY GRAVITY EX-VIVO FOR RED-CELL REDUCTION OF GRANULOCYTE APHERESIS COMPONENTS
    Journal of clinical apheresis
    
    D. Adkins et al., "HYDROXYETHYLSTARCH SEDIMENTATION BY GRAVITY EX-VIVO FOR RED-CELL REDUCTION OF GRANULOCYTE APHERESIS COMPONENTS", Journal of clinical apheresis, 13(2), 1998, pp. 56-61
16. KHOURY H; ADKINS D; ZEHNBAUER B; GOODNOUGH L; BROWN R; SAFDAR S; DIPERSIO JF
    ESSENTIAL THROMBOCYTHEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    Bone marrow transplantation
    
    H. Khoury et al., "ESSENTIAL THROMBOCYTHEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA", Bone marrow transplantation, 22(1), 1998, pp. 107-109
17. ADKINS D; BROWN R; GOODNOUGH LT; KHOURY H; POPOVIC W; DIPERSIO J
    TREATMENT OF RESISTANT MANTLE CELL LYMPHOMA WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION
    Bone marrow transplantation
    
    D. Adkins et al., "TREATMENT OF RESISTANT MANTLE CELL LYMPHOMA WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION", Bone marrow transplantation, 21(1), 1998, pp. 97-99
18. ADKINS D; ALI S; DESPOTIS G; DYNIS M; GOODNOUGH LT
    GRANULOCYTE COLLECTION EFFICIENCY AND YIELD ARE ENHANCED BY THE USE OF A HIGHER INTERFACE OFFSET DURING APHERESIS OF DONORS GIVEN GRANULOCYTE-COLONY-STIMULATING FACTOR
    Transfusion
    
    D. Adkins et al., "GRANULOCYTE COLLECTION EFFICIENCY AND YIELD ARE ENHANCED BY THE USE OF A HIGHER INTERFACE OFFSET DURING APHERESIS OF DONORS GIVEN GRANULOCYTE-COLONY-STIMULATING FACTOR", Transfusion, 38(6), 1998, pp. 557-564
19. BROWN RA; ADKINS D; GOODNOUGH LT; HAUG JS; TODD G; WEHDE M; HENDRICKS D; EHLENBECK C; LAUB L; DIPERSIO J
    FACTORS THAT INFLUENCE THE COLLECTION AND ENGRAFTMENT OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    Journal of clinical oncology
    
    R.A. Brown et al., "FACTORS THAT INFLUENCE THE COLLECTION AND ENGRAFTMENT OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES", Journal of clinical oncology, 15(9), 1997, pp. 3067-3074
20. GAJEWSKI J; WALL D; ADKINS D; GELLER R; YVER A; LLOYD K; SOUZA S; CHAMPLIN R
    A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION WITH CD5 8 CELLECTOR(R) IN ADDITION TO CYCLOSPORINE, METHOTREXATE AND STEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE PREVENTION IN HLA MISMATCHED BONE-MARROW TRANSPLANT/
    Experimental hematology
    
    J. Gajewski et al., "A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION WITH CD5 8 CELLECTOR(R) IN ADDITION TO CYCLOSPORINE, METHOTREXATE AND STEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE PREVENTION IN HLA MISMATCHED BONE-MARROW TRANSPLANT/", Experimental hematology, 25(8), 1997, pp. 292-292
21. KHOURY H; ADKINS D; MILLER G; GOODNOUGH L; BROWN R; DIPERSIO J
    RESOLUTION OF INVASIVE CENTRAL-NERVOUS-SYSTEM ASPERGILLOSIS IN A TRANSPLANT RECIPIENT
    Bone marrow transplantation
    
    H. Khoury et al., "RESOLUTION OF INVASIVE CENTRAL-NERVOUS-SYSTEM ASPERGILLOSIS IN A TRANSPLANT RECIPIENT", Bone marrow transplantation, 20(2), 1997, pp. 179-180
22. SPITZER G; ADKINS D; MATHEWS M; VELASQUEZ W; BOWERS C; DUNPHY F; KRONMUELLER N; NIEMEYER R; MCINTYRE W; PETRUSKA P
    RANDOMIZED COMPARISON OF G-CSF-CSF VS G-CSF ALONE FOR MOBILIZATION OFPERIPHERAL-BLOOD STEM-CELLS - EFFECTS ON HEMATOPOIETIC RECOVERY AFTERHIGH-DOSE CHEMOTHERAPY(GM)
    Bone marrow transplantation
    
    G. Spitzer et al., "RANDOMIZED COMPARISON OF G-CSF-CSF VS G-CSF ALONE FOR MOBILIZATION OFPERIPHERAL-BLOOD STEM-CELLS - EFFECTS ON HEMATOPOIETIC RECOVERY AFTERHIGH-DOSE CHEMOTHERAPY(GM)", Bone marrow transplantation, 20(11), 1997, pp. 921-930
23. TSAI T; GOODMAN S; SAEZ R; SCHILLER G; ADKINS D; CALLANDER N; WOLFF S; FREYTES CO
    ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION
    Bone marrow transplantation
    
    T. Tsai et al., "ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION", Bone marrow transplantation, 20(10), 1997, pp. 859-863
24. ADKINS D; GOODGOLD H; HENDERSHOTT L; JOHNSTON M; CRAVENS D; SPITZER G
    INDIUM-LABELED WHITE BLOOD-CELLS APHERESED FROM DONORS RECEIVING G-CSF LOCALIZE TO SITES OF INFLAMMATION WHEN INFUSED INTO ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS
    Bone marrow transplantation
    
    D. Adkins et al., "INDIUM-LABELED WHITE BLOOD-CELLS APHERESED FROM DONORS RECEIVING G-CSF LOCALIZE TO SITES OF INFLAMMATION WHEN INFUSED INTO ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS", Bone marrow transplantation, 19(8), 1997, pp. 809-812
25. FORD C; SPITZER G; REILLY W; ADKINS D
    A PHASE-II STUDY OF REPETITIVE CYCLES OF DOSE-INTENSE CARBOPLATIN PLUS PACLITAXEL CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELLS IN METASTATIC BREAST-CANCER
    Seminars in oncology
    
    C. Ford et al., "A PHASE-II STUDY OF REPETITIVE CYCLES OF DOSE-INTENSE CARBOPLATIN PLUS PACLITAXEL CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELLS IN METASTATIC BREAST-CANCER", Seminars in oncology, 24(5), 1997, pp. 81-86
26. ADKINS D; SPITZER G; JOHNSTON M; VELASQUEZ W; DUNPHY F; PETRUSKA P
    TRANSFUSIONS OF GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED GRANULOCYTE COMPONENTS TO ALLOGENEIC TRANSPLANT RECIPIENTS - ANALYSIS OF KINETICS AND FACTORS DETERMINING POSTTRANSFUSION NEUTROPHIL AND PLATELETCOUNTS
    Transfusion
    
    D. Adkins et al., "TRANSFUSIONS OF GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED GRANULOCYTE COMPONENTS TO ALLOGENEIC TRANSPLANT RECIPIENTS - ANALYSIS OF KINETICS AND FACTORS DETERMINING POSTTRANSFUSION NEUTROPHIL AND PLATELETCOUNTS", Transfusion, 37(7), 1997, pp. 737-748
27. ADKINS D; GOODNOUGH LT; BROWN R; KHOURY H; FEARS C; DIPERSIO J
    G-CSF MOBILIZED GRANULOCYTE COMPONENTS TRANSFUSED INTO AUTOLOGOUS TRANSPLANT RECIPIENTS RESULTS IN SIGNIFICANT AND SUSTAINED ABSOLUTE NEUTROPHIL COUNT (ANC) INCREMENTS
    Blood
    
    D. Adkins et al., "G-CSF MOBILIZED GRANULOCYTE COMPONENTS TRANSFUSED INTO AUTOLOGOUS TRANSPLANT RECIPIENTS RESULTS IN SIGNIFICANT AND SUSTAINED ABSOLUTE NEUTROPHIL COUNT (ANC) INCREMENTS", Blood, 90(10), 1997, pp. 3278-3278
28. TODD G; HAUG JS; BREMER R; LINK D; GOODNOUGH L; ADKINS D; BROWN R; DIPERSIO J
    STEADY-STATE CD14-LEVELS VARY ACCORDING TO SEX AND AGE(LINEAGE)
    Blood
    
    G. Todd et al., "STEADY-STATE CD14-LEVELS VARY ACCORDING TO SEX AND AGE(LINEAGE)", Blood, 90(10), 1997, pp. 4267-4267
29. ADKINS D; SPITZER G; BROWN R; KHOURY H; GOODNOUGH T; TRIMBUR T; LIN H; DIPERSIO J
    LOW-INTENSITY CONDITIONING FOR RELATED DONOR ALLOGENEIC TRANSPLANT USING HIGH-DOSE-RATE LOW-DOSE (550 CGY) SINGLE EXPOSURE TOTAL-BODY IRRADIATION (TBI)
    Blood
    
    D. Adkins et al., "LOW-INTENSITY CONDITIONING FOR RELATED DONOR ALLOGENEIC TRANSPLANT USING HIGH-DOSE-RATE LOW-DOSE (550 CGY) SINGLE EXPOSURE TOTAL-BODY IRRADIATION (TBI)", Blood, 90(10), 1997, pp. 4481-4481
30. RICHART JM; MCINTYRE W; KLEBERT K; PETRUSKA P; ADKINS D; DUNPHY F; PINCUS S
    ADDITION OF ETOPOSIDE TO CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION AS A CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE DISEASE-FREE SURVIVAL IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    Blood
    
    J.M. Richart et al., "ADDITION OF ETOPOSIDE TO CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION AS A CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE DISEASE-FREE SURVIVAL IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES", Blood, 90(10), 1997, pp. 4510-4510
31. GAJEWSKI J; WALL D; ADKINS D; GELLER R; YVER A; LLOYD K; SOUZA S; CHAMPLIN R
    A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION WITH CD5 8 COLLECTOR(R) IN ADDITION TO CYCLOSPORINE, METHOTREXATE AND STEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE PREVENTION IN HLA MISMATCHED OR UNRELATED BONE-MARROW TRANSPLANT/
    Blood
    
    J. Gajewski et al., "A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION WITH CD5 8 COLLECTOR(R) IN ADDITION TO CYCLOSPORINE, METHOTREXATE AND STEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE PREVENTION IN HLA MISMATCHED OR UNRELATED BONE-MARROW TRANSPLANT/", Blood, 90(10), 1997, pp. 4527-4527
32. TODD G; HAUG JS; BREMER R; LINK D; GOODNOUGH L; ADKINS D; BROWN R; DIPERSIO J
    FLT3 LIGAND LEVELS VARY BEFORE AND DURING G-CSF MOBILIZATION
    Blood
    
    G. Todd et al., "FLT3 LIGAND LEVELS VARY BEFORE AND DURING G-CSF MOBILIZATION", Blood, 90(10), 1997, pp. 931-931
33. KHOURY H; ADKINS D; BROWN R; MILLER G; GOODNOUQH LT; DIPERSIO J
    TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE (VOD) WITH HIGH-DOSE CORTICOSTEROIDS - RESULTS IN 20 STEM-CELL TRANSPLANT RECIPIENTS
    Blood
    
    H. Khoury et al., "TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE (VOD) WITH HIGH-DOSE CORTICOSTEROIDS - RESULTS IN 20 STEM-CELL TRANSPLANT RECIPIENTS", Blood, 90(10), 1997, pp. 970-970
34. BROWN RA; ADKINS D; DIPERSIO J; GOODNOUGH T
    ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSC) IS ASSOCIATED WITH AN INCREASED RISK OF CHRONIC GRAFT-VS-HOST DISEASE
    Blood
    
    R.A. Brown et al., "ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSC) IS ASSOCIATED WITH AN INCREASED RISK OF CHRONIC GRAFT-VS-HOST DISEASE", Blood, 90(10), 1997, pp. 991-991
35. SHENOY S; BROWN R; ADKINS D; DIPERSIO J; MOHANAKUMAR T
    CONSTITUTIVE PERIPHERAL-BLOOD CYTOKINE M-RNA EXPRESSION IN GROWTH-FACTOR MOBILIZED NORMAL DONORS AND ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT (PBSCT) RECIPIENTS
    Blood
    
    S. Shenoy et al., "CONSTITUTIVE PERIPHERAL-BLOOD CYTOKINE M-RNA EXPRESSION IN GROWTH-FACTOR MOBILIZED NORMAL DONORS AND ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT (PBSCT) RECIPIENTS", Blood, 90(10), 1997, pp. 2501-2501
36. FREYTES CO; VUKELJA S; SALZMAN D; TSAI T; CALLANDER N; GOKMEN E; RODRIGUEZ T; CASTRO J; BOLDT D; ROODMAN GD; HILSENBECK S; ADKINS D; BACHIER C; CRAIG F; CLARE N; WEISNER A; LEMAISTRE CF
    AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA
    Experimental hematology
    
    C.O. Freytes et al., "AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA", Experimental hematology, 24(9), 1996, pp. 629-629
37. ADKINS D; SPITZER G; BROWN R; GOODNOUGH T; FADLER M; LIN H; DIPERSIO J
    HIGH-DOSE-RATE (30 CGY MIN) LOW-DOSE (550 CGY) SINGLE EXPOSURE TOTAL-BODY IRRADIATION (TBI) AS CONDITIONING FOR ALLOGENEIC PERIPHERAL-BLOODSTEM-CELL (ALLOPBSC) TRANSPLANTATION RESULTS IN COMPLETE DONOR CHIMERISM, AND RAPID ENGRAFTMENT WITHOUT SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) OR TOXICITY/
    Blood
    
    D. Adkins et al., "HIGH-DOSE-RATE (30 CGY MIN) LOW-DOSE (550 CGY) SINGLE EXPOSURE TOTAL-BODY IRRADIATION (TBI) AS CONDITIONING FOR ALLOGENEIC PERIPHERAL-BLOODSTEM-CELL (ALLOPBSC) TRANSPLANTATION RESULTS IN COMPLETE DONOR CHIMERISM, AND RAPID ENGRAFTMENT WITHOUT SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) OR TOXICITY/", Blood, 88(10), 1996, pp. 443-443
38. GAJEWSKI J; WALL D; ADKINS D; GELLER R; YVER A; LLOYD K; SOUZA S; CHAMPLIN R
    A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION (TCD) WITH CD5 8 CELLECTOR(R) IN ADDITION TO CYCLOSPORINE (CSA), METHOTREXATE (MTX) ANDSTEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PREVENTION IN HLA MISMATCHED (MM) BONE MARRROW TRANSPLANTS (BMT)/
    Blood
    
    J. Gajewski et al., "A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION (TCD) WITH CD5 8 CELLECTOR(R) IN ADDITION TO CYCLOSPORINE (CSA), METHOTREXATE (MTX) ANDSTEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PREVENTION IN HLA MISMATCHED (MM) BONE MARRROW TRANSPLANTS (BMT)/", Blood, 88(10), 1996, pp. 1002-1002
39. ADKINS D; GOODNOUGH T; BROWN R; DIPERSIO J
    BLOOD NEUTROPHIL RESPONSE TO G-CSF AND NUMBER OF NEUTROPHILS COLLECTED PER LEUKAPHERESIS (LA) PROCEDURE
    Blood
    
    D. Adkins et al., "BLOOD NEUTROPHIL RESPONSE TO G-CSF AND NUMBER OF NEUTROPHILS COLLECTED PER LEUKAPHERESIS (LA) PROCEDURE", Blood, 88(10), 1996, pp. 1314-1314
40. ALI SM; DESPOTIS G; DYNIS M; ADKINS D; GOODNOUGH LT
    EVALUATION OF INTERFACE OFFSET IN FENWAL CS3000 ON GRANULOCYTE COLLECTION EFFICIENCY AND DONOR COUNTS
    Blood
    
    S.M. Ali et al., "EVALUATION OF INTERFACE OFFSET IN FENWAL CS3000 ON GRANULOCYTE COLLECTION EFFICIENCY AND DONOR COUNTS", Blood, 88(10), 1996, pp. 1588-1588
41. KHOURY H; ADKINS D; BROWN R; GOODNOUGH T; DIPERSIO J
    HIGH-DOSE CORTICOSTEROIDS FOR TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE (VOD) COMPLICATING STEM-CELL TRANSPLANTATION
    Blood
    
    H. Khoury et al., "HIGH-DOSE CORTICOSTEROIDS FOR TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE (VOD) COMPLICATING STEM-CELL TRANSPLANTATION", Blood, 88(10), 1996, pp. 1646-1646
42. DIPERSIO J; MARTIN B; ABBOUD CN; YARESHESKI J; ADKINS D; BROWN R
    INCREASED RATES OF CMV VIREMIA IN RECIPIENTS OF PERIPHERAL-BLOOD STEM-CELL (PBSC) ALLOGENEIC TRANSPLANTS - RATIONAL FOR BOTH PROPHYLACTIC THERAPY AND SHORT-COURSE SINGLE DAILY DOSING OF GANCICLOVIR FOR 21 DAYS
    Blood
    
    J. Dipersio et al., "INCREASED RATES OF CMV VIREMIA IN RECIPIENTS OF PERIPHERAL-BLOOD STEM-CELL (PBSC) ALLOGENEIC TRANSPLANTS - RATIONAL FOR BOTH PROPHYLACTIC THERAPY AND SHORT-COURSE SINGLE DAILY DOSING OF GANCICLOVIR FOR 21 DAYS", Blood, 88(10), 1996, pp. 1685-1685
43. TODD G; HAUG JS; BROWN R; ADKINS D; DIPERSIO JF
    THE EFFECT OF G-CSF MOBILIZATION ON LYMPHOCYTE SUBSETS, MONOCYTES, NKCELLS, RBCS, PLATELETS, AND CD34+ LIN- PROGENITORS IN NORMAL ALLOGENEIC PBSC DONORS/
    Blood
    
    G. Todd et al., "THE EFFECT OF G-CSF MOBILIZATION ON LYMPHOCYTE SUBSETS, MONOCYTES, NKCELLS, RBCS, PLATELETS, AND CD34+ LIN- PROGENITORS IN NORMAL ALLOGENEIC PBSC DONORS/", Blood, 88(10), 1996, pp. 2706-2706
44. WOODSIDE J; ADKINS D
    PATIENT-CONTROLLED ANALGESIA IN FEMALES - INCREASED USE IN SMOKERS
    Journal of addictive diseases
    
    J. Woodside e D. Adkins, "PATIENT-CONTROLLED ANALGESIA IN FEMALES - INCREASED USE IN SMOKERS", Journal of addictive diseases, 14(1), 1995, pp. 157-157
45. HEIMFELD S; THOMPSON P; LILES C; DALE D; BALDWIN G; ADKINS D; BERENSON R
    MAINTENANCE OF IN-VITRO GRANULOCYTE FUNCTION AFTER CRYOPRESERVATION
    Experimental hematology
    
    S. Heimfeld et al., "MAINTENANCE OF IN-VITRO GRANULOCYTE FUNCTION AFTER CRYOPRESERVATION", Experimental hematology, 23(8), 1995, pp. 800-800
46. SPITZER G; ADKINS D; MCINTYRE W; DUNPHY F; VELASQUEZ M; BOWERS C; PETRUSKA P
    A RANDOMIZED STUDY SHOWING DELAYED EARLY PLATELET RECOVERY AFTER TANDEM PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANT WITH USE OF GROWTH-FACTORS (GFS) POST TRANSPLANT
    Blood
    
    G. Spitzer et al., "A RANDOMIZED STUDY SHOWING DELAYED EARLY PLATELET RECOVERY AFTER TANDEM PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANT WITH USE OF GROWTH-FACTORS (GFS) POST TRANSPLANT", Blood, 86(10), 1995, pp. 399-399
47. BROWN RA; ADKINS D; GOODNOUGH T; WEHDE M; HENDRICKS D; EHLENBECK C; LAUB L; DIPERSIO J
    SEQUENTIAL INFUSION OF ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS (ALLOPBPC) CAN ELIMINATE PROFOUND NEUTROPENIA FOLLOWING TRANSPLANT
    Blood
    
    R.A. Brown et al., "SEQUENTIAL INFUSION OF ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS (ALLOPBPC) CAN ELIMINATE PROFOUND NEUTROPENIA FOLLOWING TRANSPLANT", Blood, 86(10), 1995, pp. 1157-1157
48. BROWN RA; ADKINS D; GOODNOUGH T; WEHDE M; HENDRICKS D; EHLENBECK C; LAUB L; DIPERSIO J
    ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANT DOES NOT APPEAR TO INCREASE THE RISK OF ACUTE GRAFT-VS-HOST DISEASE (GVHD) FOLLOWING HLA IDENTICAL SIBLING TRANSPLANT
    Blood
    
    R.A. Brown et al., "ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANT DOES NOT APPEAR TO INCREASE THE RISK OF ACUTE GRAFT-VS-HOST DISEASE (GVHD) FOLLOWING HLA IDENTICAL SIBLING TRANSPLANT", Blood, 86(10), 1995, pp. 1561-1561
49. ADKINS D; BORSON R; TABATABAI A; GOODNOUGH L; BROWN R; DIPERSIO J
    RAPID NEUTROPHIL AND PLATELET RECOVERY OCCURS AFTER HIGH-DOSE THERAPY(HDT) GIVEN WITHOUT POSTTRANSPLANT MYELOID GROWTH-FACTORS (GFS) WHEN INFUSED PERIPHERAL-BLOOD STEM-CELL (PBSC) PRODUCTS CONTAIN GREATER-THAN 2X10(6) CD34+ CELLS KG/
    Blood
    
    D. Adkins et al., "RAPID NEUTROPHIL AND PLATELET RECOVERY OCCURS AFTER HIGH-DOSE THERAPY(HDT) GIVEN WITHOUT POSTTRANSPLANT MYELOID GROWTH-FACTORS (GFS) WHEN INFUSED PERIPHERAL-BLOOD STEM-CELL (PBSC) PRODUCTS CONTAIN GREATER-THAN 2X10(6) CD34+ CELLS KG/", Blood, 86(10), 1995, pp. 1604-1604
50. GOODNOUGH LT; BROWN R; ADKINS D; DIPERSIO J
    AN ANALYSIS OF ELDERLY (AGE GREATER-THAN-OR-EQUAL-TO-50 YEARS) ALLOGENEIC STEM-CELL PHERESIS DONORS
    Blood
    
    L.T. Goodnough et al., "AN ANALYSIS OF ELDERLY (AGE GREATER-THAN-OR-EQUAL-TO-50 YEARS) ALLOGENEIC STEM-CELL PHERESIS DONORS", Blood, 86(10), 1995, pp. 2306-2306
51. BROWN RA; ADKINS D; GOODNOUGH T; WEHDE M; HENDRICKS D; EHLENBECK C; LAUB L; DIPERSIO J
    THE LARGE MAJORITY OF NORMAL DONORS ONLY REQUIRE A SINGLE, 20 LITER PHERESIS PROCEDURE TO COLLECT ADEQUATE CELLS FOR ALLOGENEIC TRANSPLANT
    Blood
    
    R.A. Brown et al., "THE LARGE MAJORITY OF NORMAL DONORS ONLY REQUIRE A SINGLE, 20 LITER PHERESIS PROCEDURE TO COLLECT ADEQUATE CELLS FOR ALLOGENEIC TRANSPLANT", Blood, 86(10), 1995, pp. 2307-2307
52. ADKINS D; GOODGOLD H; HENDERSHOTT L; JOHNSTON M; CRAVENS D; SPITZER G
    INDIUM-LABELED WHITE BLOOD-CELLS (WBC) OBTAINED FROM BONE-MARROW DONORS RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR (C-CSF) LOCALIZE TOSITES OF INFLAMMATION WHEN INFUSED INTO ALLOGENEIC BONE-MARROW TRANSPLANT (ALLO-BMT) RECIPIENTS
    Blood
    
    D. Adkins et al., "INDIUM-LABELED WHITE BLOOD-CELLS (WBC) OBTAINED FROM BONE-MARROW DONORS RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR (C-CSF) LOCALIZE TOSITES OF INFLAMMATION WHEN INFUSED INTO ALLOGENEIC BONE-MARROW TRANSPLANT (ALLO-BMT) RECIPIENTS", Blood, 86(10), 1995, pp. 2316-2316
53. ADKINS D; JOHNSTON M; CRAVENS D; DUNPHY C; WALSH J; VELASQUEZ W; PETRUSKA P; BOWERS C; DUNPHY F; SPITZER G
    SIGNIFICANT PROLONGED INCREMENTS IN THE ABSOLUTE NEUTROPHIL COUNT (ANC) OF ALLOGENEIC BONE-MARROW TRANSPLANT (ALLO-BMT) RECIPIENTS (R) OCCURS WITH PROPHYLACTIC NEUTROPHIL INFUSIONS (INF) OBTAINED FROM HLA MATCHED DONORS (D) RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)
    Blood
    
    D. Adkins et al., "SIGNIFICANT PROLONGED INCREMENTS IN THE ABSOLUTE NEUTROPHIL COUNT (ANC) OF ALLOGENEIC BONE-MARROW TRANSPLANT (ALLO-BMT) RECIPIENTS (R) OCCURS WITH PROPHYLACTIC NEUTROPHIL INFUSIONS (INF) OBTAINED FROM HLA MATCHED DONORS (D) RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)", Blood, 86(10), 1995, pp. 2317-2317
54. TSAI T; GOODMAN S; SCHILLER G; ADKINS D; CALLANDER N; WOLFF S; FREYTES C
    ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AUTO BMT) IN LYMPHOMAS AND ACUTE-LEUKEMIA
    Blood
    
    T. Tsai et al., "ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AUTO BMT) IN LYMPHOMAS AND ACUTE-LEUKEMIA", Blood, 86(10), 1995, pp. 3864-3864
55. TSAI T; SALZMAN D; CLARK G; CASTRO J; CALLANDER N; BOLDT D; ROODMAN GD; SHERIDANLEOS N; WIESNER A; ADKINS D; HARRIS K; RODRIGUEZ T; GOKMEN E; LEMAISTRE CF; FREYTES CO
    AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/
    Blood
    
    T. Tsai et al., "AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/", Blood, 86(10), 1995, pp. 3865-3865
56. ADKINS D; JOHNSTON M; GOODNOUGH L; CRAVENS D; WALSH J; SPITZER G
    HYDROXYETHYLSTARCH (HES) SEDIMENTATION (SED) IS INADEQUATE FOR RED-BLOOD-CELL (RBC) DEPLETION OF G-CSF PRIMED NEUTROPHIL PRODUCTS APHERESEDFROM HLA MATCHED BONE-MARROW (BM) DONORS, AND RESULTS IN SIGNIFICANT LOSS OF NEUTROPHIL AND PLATELET COMPONENTS
    Blood
    
    D. Adkins et al., "HYDROXYETHYLSTARCH (HES) SEDIMENTATION (SED) IS INADEQUATE FOR RED-BLOOD-CELL (RBC) DEPLETION OF G-CSF PRIMED NEUTROPHIL PRODUCTS APHERESEDFROM HLA MATCHED BONE-MARROW (BM) DONORS, AND RESULTS IN SIGNIFICANT LOSS OF NEUTROPHIL AND PLATELET COMPONENTS", Blood, 86(10), 1995, pp. 3903-3903
57. DANFORD DA; KUGLER JD; DEAL B; CASE C; FRIEDMAN RA; SAUL JP; SILKA MJ; VANHARE GF; ERICKSON C; CAMPBELL R; HULSE JE; WALSH E; KARPAWICH P; PERRY JC; ROSS B; BENSON DW; STERBA R; HORDOFF AJ; SCHAFFER MS; KANTER RJ; EPSTEIN M; COHEN M; KUEHL K; BEDER S; ADKINS D; MCCORMACK J; KURER C; WOLFF G; YOUNG ML; DICK M; BURTON D; GILLETTE PC; BROMBERG B; FENRICH AL; HAMILTON R; GOW R; FISH F
    THE LEARNING-CURVE FOR RADIOFREQUENCY ABLATION OF TACHYARRHYTHMIAS INPEDIATRIC-PATIENTS
    The American journal of cardiology
    
    D.A. Danford et al., "THE LEARNING-CURVE FOR RADIOFREQUENCY ABLATION OF TACHYARRHYTHMIAS INPEDIATRIC-PATIENTS", The American journal of cardiology, 75(8), 1995, pp. 587-590
58. ZIMMERMAN S; ADKINS D; GRAHAM M; PETRUSKA P; BOWERS C; VRAHNOS D; SPITZER G
    CASE-REPORT - IRREVERSIBLE, SEVERE CONGESTIVE CARDIOMYOPATHY OCCURRING IN ASSOCIATION WITH INTERFERON-ALPHA THERAPY
    Cancer biotherapy
    
    S. Zimmerman et al., "CASE-REPORT - IRREVERSIBLE, SEVERE CONGESTIVE CARDIOMYOPATHY OCCURRING IN ASSOCIATION WITH INTERFERON-ALPHA THERAPY", Cancer biotherapy, 9(4), 1994, pp. 291-299
59. SPITZER G; MATHEWS M; DUNPHY F; BOWERS C; PETRUSKA P; VELASQUEZ W; BROUN G; KRONMUELLER N; NIEMEYER R; MCINTYRE W; ADKINS D
    ARE GROWTH-FACTOR (GF) COMBINATIONS SUPERIOR TO G-CSF ALONE FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC) - A RANDOMIZED STUDY COMPARING G-CSF TO G-CSF WITH GM-CSF FOR PBSC MOBILIZATION
    Blood
    
    G. Spitzer et al., "ARE GROWTH-FACTOR (GF) COMBINATIONS SUPERIOR TO G-CSF ALONE FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC) - A RANDOMIZED STUDY COMPARING G-CSF TO G-CSF WITH GM-CSF FOR PBSC MOBILIZATION", Blood, 84(10), 1994, pp. 10000107-10000107
60. BOWERS C; ADKINS D; DUNPHY F; HARRISON B; LEMAISTRE CF; SPITZER G
    DOSE-ESCALATION OF MITOXANTRONE GIVEN WITH THIOTEPA AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR METASTATIC BREAST-CANCER
    Bone marrow transplantation
    
    C. Bowers et al., "DOSE-ESCALATION OF MITOXANTRONE GIVEN WITH THIOTEPA AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR METASTATIC BREAST-CANCER", Bone marrow transplantation, 12(5), 1993, pp. 525-530
61. ADKINS D; ENCARNACION C; SALZMAN D; BOLDT D; FREYTES C; VONHOFF DD; LEMAISTRE CF
    DURABLE COMPLETE REMISSION IN A PATIENT WITH REFRACTORY MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMOR AFTER TANDEM HIGH-DOSE CHEMOTHERAPY ANDAUTOLOGOUS BONE-MARROW TRANSPLANTATION
    Bone marrow transplantation
    
    D. Adkins et al., "DURABLE COMPLETE REMISSION IN A PATIENT WITH REFRACTORY MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMOR AFTER TANDEM HIGH-DOSE CHEMOTHERAPY ANDAUTOLOGOUS BONE-MARROW TRANSPLANTATION", Bone marrow transplantation, 12(5), 1993, pp. 541-546
62. SPITZER G; ADKINS D; DUNPHY F; PETRUSKA P; SPENCER V; VELASQUEZ W
    DESIGN OF PREPARATIVE REGIMENS FOR STEM-CELL TRANSPLANTATION IN BREAST-CANCER
    Breast cancer research and treatment
    
    G. Spitzer et al., "DESIGN OF PREPARATIVE REGIMENS FOR STEM-CELL TRANSPLANTATION IN BREAST-CANCER", Breast cancer research and treatment, 26, 1993, pp. 190000003-190000009
63. VELASQUEZ WS; DUNPHY F; SANTILLANA S; ADKINS D; BOWERS C; BROUN GO; PETRUSKA PJ; SPITZER G
    TANDEM HIGH-DOSE CHEMOTHERAPY REGIMENS IMPROVE DISEASE-FREE SURVIVAL IN PATIENTS WITH RELAPSING OF REFRACTORY HODGKINS (HD) AND NON-HODGKINS-LYMPHOMAS (NHL) - PRELIMINARY-REPORT
    Blood
    
    W.S. Velasquez et al., "TANDEM HIGH-DOSE CHEMOTHERAPY REGIMENS IMPROVE DISEASE-FREE SURVIVAL IN PATIENTS WITH RELAPSING OF REFRACTORY HODGKINS (HD) AND NON-HODGKINS-LYMPHOMAS (NHL) - PRELIMINARY-REPORT", Blood, 82(10), 1993, pp. 10000138-10000138
64. VELASQUEZ WS; DUNPHY F; SANTILLANA S; ADKINS D; BOWERS C; BROUN GO; PETRUSKA PJ; SPITZER G
    ASHAP, AN EFFECTIVE TREATMENT FOR RELAPSING AND REFRACTORY HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL)
    Blood
    
    W.S. Velasquez et al., "ASHAP, AN EFFECTIVE TREATMENT FOR RELAPSING AND REFRACTORY HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL)", Blood, 82(10), 1993, pp. 10000138-10000138
65. SPITZER G; SPENCER V; DUNPHY F; KULKARNI S; PETRUSKA P; VELASQUEZ W; BOWERS C; KRONMUELLER N; NIEMEYER R; MCINTYRE W; ADKINS D
    ARE GROWTH-FACTORS (GF) NEEDED AFTER PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION - A RANDOMIZED STUDY TO EVALUATE THE QUESTION
    Blood
    
    G. Spitzer et al., "ARE GROWTH-FACTORS (GF) NEEDED AFTER PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION - A RANDOMIZED STUDY TO EVALUATE THE QUESTION", Blood, 82(10), 1993, pp. 10000288-10000288
66. ADKINS D; BERENSON R; BOWERS C; BROUN G; DUNPHY F; KRONMUELLER N; PETRUSKA P; VELASQUEZ W; SPITZER G
    CD34-BLOOD STEM-CELLS (CPBSC) INFUSED AFTER HIGH-DOSE CHEMOTHERAPY (HDCT) RESULT IN EQUIVALENT HEMATOPOIETIC ENGRAFTMENT KINETICS AS COMPARED TO UNCONCENTRATED PBSC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)( CONCENTRATED PERIPHERAL)
    Blood
    
    D. Adkins et al., "CD34-BLOOD STEM-CELLS (CPBSC) INFUSED AFTER HIGH-DOSE CHEMOTHERAPY (HDCT) RESULT IN EQUIVALENT HEMATOPOIETIC ENGRAFTMENT KINETICS AS COMPARED TO UNCONCENTRATED PBSC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)( CONCENTRATED PERIPHERAL)", Blood, 82(10), 1993, pp. 10000290-10000290
67. BOWERS C; ADKINS D; DUNPHY F; PETRUSKA P; VELASQUEZ W; MCINTYRE W; NIEMEYER R; RESTA D; SPITZER G
    SIMULTANEOUS INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ADMINISTRATION AFTER HIGH-DOSE CHEMOTHERAPY(HDCT) IN PATIENTS WITH ADVANCED CANCER
    Blood
    
    C. Bowers et al., "SIMULTANEOUS INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ADMINISTRATION AFTER HIGH-DOSE CHEMOTHERAPY(HDCT) IN PATIENTS WITH ADVANCED CANCER", Blood, 82(10), 1993, pp. 10000495-10000495
68. RODRIQUEZ J; DUNPHY F; SPITZER G; VELAZQUEZ W; PETRUSKA P; ADKINS D; BOWERS C; BROUN G
    RANDOMIZED STUDY OF IN-VIVO GCSF (PRIMING) VS (NO PRIMING) BEFORE HIGH-DOSE THERAPY (HDT) WITH CYCLOPHOSPHAMIDE-ETOPOSIDE-CISPLATINUM (CVP)
    Blood
    
    J. Rodriquez et al., "RANDOMIZED STUDY OF IN-VIVO GCSF (PRIMING) VS (NO PRIMING) BEFORE HIGH-DOSE THERAPY (HDT) WITH CYCLOPHOSPHAMIDE-ETOPOSIDE-CISPLATINUM (CVP)", Blood, 82(10), 1993, pp. 10000504-10000504